Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Back burner Yes. In late 2014, Anavex began a 32-patient trial to determine a maximum tolerated dose for 2-73 in patients with mild to moderate Alzheimer's disease over 36 days.
Although located in Manhattan, Anavex is conducting the trial in treatment centers across Melbourne, Australia. Australian media news outlets have reported that one trial patient regained her ability to play piano, while another regained the ability to paint, hinting at 2-73's potential.
That was in 2014 and zero placebo controlled results expected until 2021 or 2022. That’s the back burner slow cook. If drug was any good, we would of had results in 2016 or 2017.
You stated it in your reply about the genes. My statement remains.
Lol. It won’t treat everyone if it treats anyone. Even in the reply it was stated.
Lol, Its documented. Anavex AD has already failed in many aspects.
Anavex AD trial has already failed in many aspects that’s why it’s being pushed to the back burner. Precision means it will not treat everyone if anyone. MMSE needs to be 20+, can’t have this gene, or that. Etc
Sand piper you hit $2.75 on the penny. Congrats on calling AVXL.
Power, we posted the presentation just for you.
I appreciate all of the free shares of Anavex. Contracts never get exercised. People keep believing and I keep writing them.
I love the premium. Thanks.
Anavex stock is garbage. Same place for 10 years now.
SP under $3. Bearish no bull.
Apparently marketing is needed in US as 15 patient trial is still recruiting after months. If one patient a week was dosed in US trial would be over. Rett foundation is supporting trial and it’s still not complete. Hopefully it’s done soon and provided some benefits to the girls.
Trials are blind so how would company know? Could be placebo or drug if any efficacy.
Note slide 6 is missing Topline readout years but look what does have the years next to it. Don’t count on a readout.
It’s what he doesn’t say. Misleading
https://www.anavex.com/wp-content/uploads/2019/04/Anavex-Presentation-April-2019.pdf
I consider your opinion to be uninformed or biased.
I believe his experience as an investment banker has damaged shareholders.
His prior company was "expelled" for negligence. His prior company was his training ground. .
I think Missling learned a lot in that instance and others along the way. That's why the founding investor of this company could only get missling because others have integrity.
I sent them to you before.
Reply to.
What transcripts???
Link please..
I know of no transcript that at any time revealed Missling's game plan.
I like the way it's being revealed though.
A corporate strategy that is is the most shrewd and well crafted that I have ever seen.
When the size of the submerged iceberg is understood in the general market price per share will be close to $100 or more.
Missling was there day firm was expelled.
https://brokercheck.finra.org/individual/summary/5362491
Review down page.
Plus I don’t consider missling a smart CEO. It’s the CEO skarpie could buy. Company stated in 10q/k prior to missling they wanted CEO with experience and they got a person that was an investment banker for 6 to 8 years prior. And again that company was barred and expelled.
Again, that’s the point. When does the FDA enforce trials around the globe? Blaming the FDA for trials around the world is not the answer.
Wrong, read transcripts. All 3 trials were never going to be in US.
Lol you know AXON was a scam. Bought a drug for $5 million flipped stock share price to $2 billion on pure BS.
How much was 2 73 purchased for... similarities.
My statement that The CEO is a liar has been supported by the lack of 3 trials starting in 2017 as outlined as catalyst. Just an example.
Show me proof where none of the 32 were not misdiagnosed with Alzheimer’s. You said you doubt it. Show me in a link.
Where does it state Anavex can reverse Alzheimer’s in this presentation.
https://www.anavex.com/wp-content/uploads/2019/04/Anavex-Presentation-April-2019.pdf
They don’t state it in recent presentations.
And some of the time you are wrong.
Priceless.
Won’t have any income anytime soon.
Unless MJf tosses them a bone.
Little 13itch. Xena didn’t support you. James Jones follower. Don’t drink the kool aid. B.
OMG.. plain B.S. analysis because no analysis given.
Where does it state Anavex can reverse Alzheimer’s in this presentation.
https://www.anavex.com/wp-content/uploads/2019/04/Anavex-Presentation-April-2019.pdf
It’s what you don’t see with misleading
Worthless post.
The safe harbor protects him on the timeline. Intentional perversion of the truth to make a claim like Anavex can reverse Alzheimer’s with what is known now, will IMO cause the counselors to circle.
You are correct it is bait and switch. Maybe I need some 2 73 to straighten me out. LOL.
How ridiculous to even debate such a thing. If anything newsworthy comes out, it would not come from nature magazine. Missling would be pumping to high heaven.
Lima, I’ve read everything about Anavex going back to 2010.
I can say with confidence that Missling is full of poop.
Anavex no longer states they can reverse Alzheimer’s.
Show us a recent publication with that claim
Results proves they didn’t, can’t and won’t.
Preclinical in mice maybe.
Not in the clinic.
Slow decline. Maybe yet to be proven.
Wow. I guess Anavex gets it right 100 percent of the time. Extraordinary even years ago when this trial started.
Not. B S
Was any patient out of the 32 misdiagnosed with Alzheimer’s?
https://nationalpost.com/news/world/the-pain-of-being-misdiagnosed-with-alzheimers-is-more-common-than-we-realize-doctors-say
Some people were misdiagnosed in this trial.
And you take a place we’re GPs are allowed to diagnose ALZ.
They will not make the claim of reversing Alzheimer’s based on what we have seen.
It’s called switch and bait. Now it’s a new term and new indication.
Again, Anavex has not reversed Alzheimer’s in the clinic but they reversed in mouseheimers.
Might be why they are having problems recruiting 15 patients for a 7 week trial.
The clinical proved they cannot reverse Alzheimer’s. Everyone reverses Alzheimer’s in mice. If not, you don’t get to trial.